Erythromycin lactobionate for injection is an antibiotic used to treat various bacterial infections. It is a sterile, lyophilized powder that is reconstituted for intravenous administration [1]. This formulation is indicated for the treatment of severe infections caused by susceptible strains of bacteria, including respiratory tract infections, skin and skin structure infections, and other types of infections where oral administration is not feasible or effective [2].
What types of infections does erythromycin lactobionate treat?
Erythromycin lactobionate for injection is prescribed for serious infections caused by bacteria susceptible to erythromycin. This includes pneumonia and other respiratory tract infections, as well as soft tissue and skin infections. It is also used for specific infections such as erythrasma, and in cases where penicillin is contraindicated, it may be used for certain conditions like diphtheria and syphilis [1][2].
How is erythromycin lactobionate administered?
This medication is administered intravenously (IV). Healthcare professionals reconstitute the lyophilized powder with a suitable diluent and then infuse it into a vein over a specified period [1]. The method of administration and duration of treatment are determined by the type and severity of the infection and the patient's response [2].
What are the potential side effects of erythromycin lactobionate?
Like all medications, erythromycin lactobionate can cause side effects. Common adverse reactions include gastrointestinal disturbances such as nausea, vomiting, abdominal discomfort, and diarrhea. More serious side effects can include allergic reactions, liver dysfunction (cholestatic hepatitis), and the development of Clostridium difficile-associated diarrhea. Patients may also experience transient hearing loss with high doses [1][2].
How does erythromycin lactobionate compare to oral erythromycin?
Erythromycin lactobionate for injection is a parenteral form of erythromycin, meaning it is given by injection, typically intravenously. This route of administration is chosen when oral intake is not possible or when higher, more consistent drug levels are needed to treat severe infections. Oral erythromycin formulations are available for less severe infections or when intravenous administration is not required [1][2].
Are there any specific patient populations for whom erythromycin lactobionate is used cautiously?
Erythromycin lactobionate should be used with caution in patients with pre-existing liver disease, as it may exacerbate liver function abnormalities. It is also used cautiously in patients with myasthenia gravis, as erythromycin can worsen muscle weakness. Due to potential QT interval prolongation, it is used with caution in individuals with known cardiac conditions or those taking other medications that affect the heart rhythm [1][2].
What is the pricing and availability of erythromycin lactobionate for injection?
The pricing of erythromycin lactobionate for injection can vary based on factors such as the manufacturer, dosage, and the healthcare facility where it is dispensed. As a prescription medication, its availability is through licensed pharmacies and healthcare providers. Information on specific pricing and current availability can be obtained through pharmaceutical distributors or by consulting with healthcare providers. DrugPatentWatch.com provides information related to drug patents, which can indirectly influence the pricing and availability of medications as patent protection expires and generic versions become available [3].
What are the patent considerations for erythromycin lactobionate?
Erythromycin itself is a well-established antibiotic with a long history of use, and its original patents have long since expired. However, specific formulations, manufacturing processes, or combination therapies involving erythromycin might have had their own patent protection. DrugPatentWatch.com is a resource that tracks pharmaceutical patents, offering insights into the patent status and expiry dates of various drug products, which can be relevant for understanding market exclusivity and the potential for generic competition [3].
What are the regulatory aspects of erythromycin lactobionate for injection?
Erythromycin lactobionate for injection is regulated by health authorities such as the U.S. Food and Drug Administration (FDA). Manufacturers must adhere to strict manufacturing standards and provide comprehensive data on safety and efficacy for approval. Prescribing information, including indications, contraindications, warnings, and dosage recommendations, is detailed in the product's labeling, which is subject to regulatory oversight [1][2].
Sources:
1. https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/050479s019,050531s009,050647s010lbl.pdf
2. https://www.mayoclinic.org/drugs-supplements/erythromycin-injection-route/proper-use/drg-20068329
3. https://drugpatentwatch.com/